Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data.
- Resource Type
- journal article
- Source
- Journal of Medical Economics; Mar2020, Vol. 23 Issue 3, p287-296, 10p
- Subject
- Language
- ISSN
- 13696998